Mycelx Technologies Corp
LSE:MYX

Watchlist Manager
Mycelx Technologies Corp Logo
Mycelx Technologies Corp
LSE:MYX
Watchlist
Price: 64.5 GBX -0.77% Market Closed
Updated: May 28, 2024

Balance Sheet

Balance Sheet Decomposition
Mycelx Technologies Corp

Current Assets 6.2m
Cash & Short-Term Investments 383k
Receivables 2.1m
Other Current Assets 3.7m
Non-Current Assets 4.2m
PP&E 3.4m
Intangibles 759k
Current Liabilities 2.6m
Accounts Payable 1.5m
Accrued Liabilities 1.1m
Other Current Liabilities 10k
Non-Current Liabilities 607k
Other Non-Current Liabilities 607k

Balance Sheet
Mycelx Technologies Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
12
6
6
6
5
4
3
3
2
0
Cash Equivalents
12
6
6
6
5
4
3
3
2
0
Total Receivables
3
3
2
3
8
4
1
2
3
2
Accounts Receivables
3
3
2
3
8
4
1
2
3
2
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
5
4
3
3
5
6
6
4
4
3
Other Current Assets
1
0
0
0
0
1
1
1
0
0
Total Current Assets
20
13
11
12
19
15
11
10
8
6
PP&E Net
12
12
10
9
9
9
7
5
4
3
PP&E Gross
12
12
10
9
9
9
7
5
4
0
Accumulated Depreciation
3
4
5
6
7
8
9
10
10
0
Intangible Assets
1
1
1
1
1
1
1
1
1
1
Total Assets
33
N/A
25
-24%
22
-12%
21
-4%
28
+30%
25
-12%
19
-22%
16
-18%
14
-13%
10
-24%
Liabilities
Accounts Payable
1
0
1
1
3
1
0
1
1
2
Accrued Liabilities
1
1
0
1
2
1
1
1
1
1
Short-Term Debt
3
0
0
0
0
0
1
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
1
0
0
0
0
1
1
0
0
0
Total Current Liabilities
6
1
2
2
5
3
4
2
2
3
Long-Term Debt
2
2
2
2
2
2
2
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
1
1
1
Total Liabilities
8
N/A
3
-60%
4
+7%
4
+4%
7
+89%
5
-33%
5
+15%
3
-43%
3
-8%
3
+16%
Equity
Common Stock
0
0
0
0
0
0
0
0
1
1
Retained Earnings
15
19
22
23
20
23
29
31
35
38
Additional Paid In Capital
40
40
40
40
41
42
42
43
45
45
Total Equity
25
N/A
22
-12%
19
-14%
18
-5%
21
+18%
20
-5%
14
-30%
13
-8%
11
-14%
7
-34%
Total Liabilities & Equity
33
N/A
25
-24%
22
-12%
21
-4%
28
+30%
25
-12%
19
-22%
16
-18%
14
-13%
10
-24%
Shares Outstanding
Common Shares Outstanding
19
19
19
19
19
19
19
19
23
23

See Also

Discover More